Phase 3 /Seroquel SR Acute Mania Monotherapy - US

PHASE3CompletedINTERVENTIONAL
Enrollment

447

Participants

Timeline

Start Date

January 31, 2007

Study Completion Date

July 31, 2007

Conditions
Affective Psychosis, BipolarManic DisorderManic-Depressive PsychosisManiaManic StatePsychoses, Manic-Depressive
Interventions
DRUG

Quetiapine fumarate (Seroquel) SR

Trial Locations (51)

Unknown

Research Site, Phoenix

Research Site, Little Rock

Research Site, Cerritos

Research Site, Garden Grove

Research Site, Oceanside

Research Site, Pico Rivera

Research Site, San Diego

Research Site, Santa Ana

Research Site, Torrance

Research Site, Denver

Research Site, Washington D.C.

Research Site, Aventura

Research Site, EAST Bradenton

Research Sitew, Fort Lauderdale

Research Site, Hollywood

Research Site, Leesburg

Research Site, Tampa

Research Site, Atlanta

Research Site, Honolulu

Research Site, Hoffman Estates

Research Site, Naperville

Research Site, OAK Brook Terrace

Research Site, Greenwood

Research Site, Indianapolis

Research Site, Newton

Research Site, Wichita

Research Site, Lake Charles

Research Site, New Orleans

Research Site, Shreveport

Research Site, Rockville

Research Site, St Louis

Research Site, Kenilworth

Research Site, Willingboro

Research Site, Elmsford

Research Site, Holliswood

Research Site, Durham

Research Site, Beachwood

Research Site, Oklahoma City

Research Site, Moon Township

Research Site, Philadelphia

Research Site, Charleston

Research Site, Memphis

Research Site, Nashville

Research Site, Austin

Research Site, DeSoto

Research Site, Houston

Research Site, Irving

Research Site, San Antonio

Research Site, Arlington

Research Site, Richmond

Research Site, Bellevue

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY